Target intelligence / Profile preview

Free heme and hemozoin intermediates

Molecular classification
Metabolic byproduct, Biocrystal, Porphyrin
01

Overview

Free heme and hemozoin intermediates are central components of the heme detoxification pathway in the digestive vacuole of Plasmodium falciparum (Sullivan, 2002, PMID: 12456505). During its lifecycle within human red blood cells, the parasite digests host hemoglobin, releasing ferriprotoporphyrin IX (free heme), which is toxic due to its ability to generate reactive oxygen species and disrupt lipid membranes (Egan, 2008, PMID: 18601567). To mitigate this toxicity, the parasite converts free heme into an insoluble, chemically inert crystalline form called hemozoin, also known as malaria pigment (Pagola et al., 2000, PMID: 10716456). This biocrystallization process is a validated therapeutic target; drugs such as chloroquine and quinine interfere with the formation of hemozoin by binding to heme or the crystal surface (Hempelmann, 2007, PMID: 17343618). The resulting accumulation of toxic heme intermediates leads to the destruction of the parasite's internal membranes and eventual cell death. Despite the emergence of resistance, targeting heme sequestration remains a cornerstone of antimalarial pharmacology.

Other names
Ferriprotoporphyrin IXFP-IXMalaria pigmentHemozoinBeta-hematinHaemozoin
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes oxidative stress and membrane damage within the parasite digestive vacuole.

03

Biological functions

Heme detoxificationHemoglobin catabolism
04

Disease associations

MalariaInfection
05

Safety considerations

Drug resistance mediated by PfCRT mutationsRetinal toxicity (long-term use of certain quinolines)Cardiovascular effects (QT prolongation)Neurotoxicity (associated with mefloquine)
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin pigment (microscopy)Paramagnetic properties of hemozoinHeme-derived fluorescence

Beyond the preview

Go deeper on Free heme and hemozoin intermediates.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free heme and hemozoin intermediates.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call